Evidence map›Paper›PMID 37195925›Full record

ArticlePloS one2023

AI-Driven sleep staging from actigraphy and heart rate.

Tzu-An Song, Samadrita Roy Chowdhury, Masoud Malekzadeh, Stephanie Harrison, Terri Blackwell Hoge, Susan Redline, Katie L Stone, Richa Saxena, Shaun M Purcell, Joyita Dutta

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Tzu-An SongUniversity of Massachusetts Amherst, Amherst, MA, United States of America.
Samadrita Roy ChowdhuryMassachusetts General Hospital, Boston, MA, United States of America.ORCID 0000-0001-7470-6768
Masoud MalekzadehUniversity of Massachusetts Amherst, Amherst, MA, United States of America.
Stephanie HarrisonCalifornia Pacific Medical Center Research Institute, San Francisco, CA, United States of America.
Terri Blackwell HogeCalifornia Pacific Medical Center Research Institute, San Francisco, CA, United States of America.
Susan RedlineBrigham and Women's Hospital, Boston, MA, United States of America.
Katie L StoneCalifornia Pacific Medical Center Research Institute, San Francisco, CA, United States of America.ORCID 0000-0003-2797-3171
Richa SaxenaMassachusetts General Hospital, Boston, MA, United States of America.
Shaun M PurcellBrigham and Women's Hospital, Boston, MA, United States of America.
Joyita DuttaUniversity of Massachusetts Amherst, Amherst, MA, United States of America.ORCID 0000-0002-6712-4927
California Pacific Medical Center · USUniversity of Massachusetts Amherst · USBrigham and Women's Hospital · USMassachusetts General Hospital · US

Funding

Sleep metrics from machine learning for Alzheimer's disease diagnosticsR21AG068890 · NIA · UNIVERSITY OF MASSACHUSETTS LOWELL · PI DUTTA, JOYITA, SAXENA, RICHA · 2020 to 2021
$473k
NIA NIH HHS R21 AG068890
6 · The paper itself

Abstract

Sleep is an important indicator of a person's health, and its accurate and cost-effective quantification is of great value in healthcare. The gold standard for sleep assessment and the clinical diagnosis of sleep disorders is polysomnography (PSG). However, PSG requires an overnight clinic visit and trained technicians to score the obtained multimodality data. Wrist-worn consumer devices, such as smartwatches, are a promising alternative to PSG because of their small form factor, continuous monitoring capability, and popularity. Unlike PSG, however, wearables-derived data are noisier and far less information-rich because of the fewer number of modalities and less accurate measurements due to their small form factor. Given these challenges, most consumer devices perform two-stage (i.e., sleep-wake) classification, which is inadequate for deep insights into a person's sleep health. The challenging multi-class (three, four, or five-class) staging of sleep using data from wrist-worn wearables remains unresolved. The difference in the data quality between consumer-grade wearables and lab-grade clinical equipment is the motivation behind this study. In this paper, we present an artificial intelligence (AI) technique termed sequence-to-sequence LSTM for automated mobile sleep staging (SLAMSS), which can perform three-class (wake, NREM, REM) and four-class (wake, light, deep, REM) sleep classification from activity (i.e., wrist-accelerometry-derived locomotion) and two coarse heart rate measures-both of which can be reliably obtained from a consumer-grade wrist-wearable device. Our method relies on raw time-series datasets and obviates the need for manual feature selection. We validated our model using actigraphy and coarse heart rate data from two independent study populations: the Multi-Ethnic Study of Atherosclerosis (MESA; N = 808) cohort and the Osteoporotic Fractures in Men (MrOS; N = 817) cohort. SLAMSS achieves an overall accuracy of 79%, weighted F1 score of 0.80, 77% sensitivity, and 89% specificity for three-class sleep staging and an overall accuracy of 70-72%, weighted F1 score of 0.72-0.73, 64-66% sensitivity, and 89-90% specificity for four-class sleep staging in the MESA cohort. It yielded an overall accuracy of 77%, weighted F1 score of 0.77, 74% sensitivity, and 88% specificity for three-class sleep staging and an overall accuracy of 68-69%, weighted F1 score of 0.68-0.69, 60-63% sensitivity, and 88-89% specificity for four-class sleep staging in the MrOS cohort. These results were achieved with feature-poor inputs with a low temporal resolution. In addition, we extended our three-class staging model to an unrelated Apple Watch dataset. Importantly, SLAMSS predicts the duration of each sleep stage with high accuracy. This is especially significant for four-class sleep staging, where deep sleep is severely underrepresented. We show that, by appropriately choosing the loss function to address the inherent class imbalance, our method can accurately estimate deep sleep time (SLAMSS/MESA: 0.61±0.69 hours, PSG/MESA ground truth: 0.60±0.60 hours; SLAMSS/MrOS: 0.53±0.66 hours, PSG/MrOS ground truth: 0.55±0.57 hours;). Deep sleep quality and quantity are vital metrics and early indicators for a number of diseases. Our method, which enables accurate deep sleep estimation from wearables-derived data, is therefore promising for a variety of clinical applications requiring long-term deep sleep monitoring.

Indexed as

ActigraphyArtificial IntelligenceHeart RateHumansMaleReproducibility of ResultsSleepSleep StagesTime Factors

Identifiers

PMID37195925
PMCPMC10191307
OpenAlexW4376958726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.